The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
Pacemakers
This channel includes news and new technology innovations for pacemakers used to treat bradycardia.
-
-
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-...
-
May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm Scientific Sessions.
-
The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare providers and patients about issues that may cause batteries in certain Medtronic implantable...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo...
News | EP Lab | July 31, 2019
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
News | Hypertension | June 04, 2019
June 4, 2019 — Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato...
Feature | HRS | May 15, 2019 | Dave Fornell, Editor
May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-...
![A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1] The new scoring system was presented as a follow up to that study during a late-breaking session at Heart Rhythm 2019, the Heart Rhythm Society's 40th Annual Scientific Sessions.](https://sgcweb.s3.wasabisys.com/dicardiology/s3fs-public/styles/content_feed_medium/public/PADIT_Infection_Risk_score.jpg?itok=sF0KB0mC)
Figure 1: The PADIT infection risk score ranging from 0 to 14 points classified patients into three risk groups, low (0-4), intermediate (5-6) and high (≥7). The risk groups had rates of hospitalization for infection of 0.51%, 1.42% and 3.41%, respectively
News | EP Lab | May 15, 2019
May 15, 2019 — A new infection risk scoring system has been developed based on data from the large PADIT Trial.[1]...
A new study shows travelers with common cardiac devices can pass through airport body scanners without restrictions or precautions.
News | EP Lab | May 14, 2019
May 14, 2019 – Results from new research show that passengers with cardiac implantable electronic devices (CIEDs),...
News | EP Lab | May 13, 2019
May 13, 2019 – Results from a new survey are the first to report a large discrepancy in patient’s knowledge of their...
News | Pacemakers | May 07, 2019 | Dave Fornell, Editor
May 7, 2019 — The U.S. Food and Drug Administration (FDA) issued a safety communication to alert healthcare...
News | Pacemakers | March 29, 2019
March 29, 2019 — A research team from Imperial College London believes a new software could speed up the diagnosis...
Technology | Heart Failure | March 21, 2019
March 21, 2019 — The U.S. Food and Drug Administration (FDA) approved Impulse Dynamics’ Optimizer Smart system for...
News | Pacemakers | February 20, 2019
February 20, 2019 — Medtronic is recalling its dual chamber implantable pulse generators (IPGs) due to the...
An implanted ICD showing its three leads in the venous system.
Feature | EP Lab | January 13, 2019 | Dave Fornell, Editor
To extract or abandon broken or infected implantable, venous...
Medtronic is issuing a software update to address a safety risk caused by cybersecurity vulnerabilities associated with the internet connection between the Carelink 2090 and Carelink Encore 29901 implantable EP device programmers.
Feature | Cybersecurity | October 17, 2018
October 17, 2018 — The U.S. Food and Drug Administration (FDA) has reviewed information about potential...
News | Hypertension | October 02, 2018
October 2, 2018 — Two-year results of the Moderato I Study demonstrated immediate, substantial and sustained...
